PNG budget delays cut medicines

Papua New Guinea’s medicines problem is not only about procurement or transport. New research from Manus province argues that the timing of public money is itself part of the clinical supply chain. When budgeted funds arrive late or cannot be spent quickly, clinics and hospitals can run short of basic drugs even when money has been allocated on paper. (devpolicy.org) The study, published on August 6 by the Development Policy Centre, drew on a structured survey conducted in Manus from August to December 2025. (devpolicy.org) It says delays in budget release and execution were widely reported by frontline workers as a major contributor to shortages in health facilities across the island province. (who.int) ### How does a budget delay become a stockout? Manus province has one provincial hospital, plus urban clinics, rural health centres and aid posts serving communities spread across islands, the researchers said. In that setting, they wrote, thin buffer stocks and difficult geography mean delays in funding are felt quickly at pharmacy counters and outpatient wards. (devpolicy.org) The researchers said a budget allocation is not enough if money does not arrive on time, cannot be spent, or does not translate into medicines on shelves. Their argument is straightforward: financing delays interrupt ordering, replenishment and routine service delivery long before patients see the administrative cause. (devpolicy.org) ### What did health workers in Manus report? The Manus survey involved 172 health workers and stakeholders, including nurses, community health workers, pharmacy staff and administrators. The authors said the findings were descriptive and based on reported experience and perception, but they also said those reports offered frontline evidence of how budget execution problems were being experienced in facilities. (devpolicy.org) Among respondents, 44% said essential-medicine stockouts occurred “sometimes,” or every few months. Another 22.7% said stockouts happened “often,” or monthly, while 14.5% said medicines were “always” out of stock; only 1.7% said they had never experienced shortages. (devpolicy.org) ### Which medicines were missing most often? Antibiotics featured most prominently in the reported shortages. The study said antibiotics, particularly amoxicillin, accounted for 28% of reported stockouts, while pain relievers such as paracetamol accounted for 26.8%. Medicines for chronic diseases and antimalarials were also commonly reported as missing. (devpolicy.org) Those are not specialist products. They are routine medicines used in primary care, which means even ordinary consultations can be disrupted when stocks run out. Respondents told the researchers that patients were often asked to buy medicines privately, had treatment delayed, saw their condition worsen, or were referred elsewhere. (devpolicy.org) ### Why does this matter beyond Manus? Papua New Guinea’s Treasury says the 2026 national budget was presented to parliament on November 25, 2025, setting out the government’s spending plans for the year. The Manus research adds that annual appropriations alone do not guarantee timely access to medicines at facility level. (devpolicy.org) The World Health Organization said from July 27 to 29, 2026, the National Department of Health, provincial health authorities and partners met in Port Moresby to review a draft Medical Supplies Strategic Plan for 2027–2031. WHO said the consultation focused on structural problems including financing, procurement, warehousing, distribution, inventory management and accountability. (devpolicy.org) ### What happens next in Papua New Guinea’s supply system? The draft Medical Supplies Strategic Plan 2027–2031 is intended to guide a coordinated national response to persistent gaps in access to essential medicines and health commodities, WHO said. The plan assigns national policy and central operational functions to the National Department of Health, while provincial health authorities would handle provincial and facility-level supply responsibilities under national standards. (treasury.gov.pg) In practical terms, that next step will be watched against the kind of failures described in Manus: delayed releases, missed replenishment and empty shelves for basic drugs. The named participants in the late-July consultation included Health Minister Billy Joseph, Health Secretary Pascoe Kase and WHO representative Rajendra Yadav. (who.int)